152 related articles for article (PubMed ID: 23426277)
1. Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C.
Hodo Y; Honda M; Tanaka A; Nomura Y; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Sakai A; Sasaki M; Nakanuma Y; Moriyama M; Kaneko S
Clin Cancer Res; 2013 Apr; 19(7):1827-37. PubMed ID: 23426277
[TBL] [Abstract][Full Text] [Related]
2. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
3. IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Terashima T; Honda M; Toyama T; Shimakami T; Shimizu R; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Gastroenterol Hepatol; 2020 Oct; 35(10):1813-1820. PubMed ID: 32180251
[TBL] [Abstract][Full Text] [Related]
4. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma].
Wang Y; Zhang HH; Chen YH; Xie XW; Liao WJ; Qin LL; Sun XY; Fei R; Wang XY; Wei L; Chen HS; Mei MH
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):527-32. PubMed ID: 22943900
[TBL] [Abstract][Full Text] [Related]
6. [PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].
Ogurtsov PP; Kukhareva EI
Klin Med (Mosk); 2016; 94(3):224-30. PubMed ID: 27522730
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Asahina Y; Tsuchiya K; Nishimura T; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Enomoto N; Nakagawa M; Kakinuma S; Watanabe M; Izumi N
J Gastroenterol; 2014 Jul; 49(7):1152-62. PubMed ID: 23860735
[TBL] [Abstract][Full Text] [Related]
10. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.
Alborzi A; Hashempour T; Moayedi J; Musavi Z; Pouladfar G; Merat S
Med Microbiol Immunol; 2017 Apr; 206(2):165-174. PubMed ID: 28214926
[TBL] [Abstract][Full Text] [Related]
11. Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing Analysis.
Chiu KW; Nakano T; Chen KD; Hu TH; Lin CC; Hsu LW; Chen CL; Goto S
Biomed Res Int; 2018; 2018():1826140. PubMed ID: 29686997
[TBL] [Abstract][Full Text] [Related]
12. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the relationship between polymorphism of IL-28B rs8099917 and the outcome of HBV infection].
Jiao XL; Gao YT; Jing L; Liu T; Shi WX; Guo H; Yang B; DU Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1143-7. PubMed ID: 22336553
[TBL] [Abstract][Full Text] [Related]
14. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population.
Li Y; Shi Y; Chen J; Cai B; Ying B; Wang L
Int J Immunogenet; 2012 Aug; 39(4):346-52. PubMed ID: 22325058
[TBL] [Abstract][Full Text] [Related]
16. IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Sato M; Kato N; Tateishi R; Muroyama R; Kowatari N; Li W; Goto K; Otsuka M; Shiina S; Yoshida H; Omata M; Koike K
J Gastroenterol; 2014 Apr; 49(4):748-54. PubMed ID: 23689989
[TBL] [Abstract][Full Text] [Related]
17. Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis.
Xia P; Zhou M; Dong DS; Xing YN; Bai Y
Tumour Biol; 2014 Feb; 35(2):1129-37. PubMed ID: 24026885
[TBL] [Abstract][Full Text] [Related]
18. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma.
Kawaoka T; Aikata H; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Takahashi S; Ochi H; Tashiro H; Ohdan H; Chayama K
J Viral Hepat; 2011 Oct; 18(10):e550-60. PubMed ID: 21914076
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.
Huang CF; Yeh ML; Hsieh MH; Hsieh MY; Lin ZY; Chen SC; Wang LY; Huang JF; Juo SH; Lin YC; Dai CY; Chuang WL; Yu ML
J Gastroenterol Hepatol; 2013 Sep; 28(9):1515-20. PubMed ID: 23560893
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
